Updated on 28 May 2015
AstraZeneca Pharma India today reported a net profit of Rs. 38.12 crore for the fourth quarter ended March 31, 2015. Net sales for the same period is at Rs 120.80 crore, while the same were at Rs 114.14 crore during the same period in the previous fiscal.
For the year ended March 31, the company posted a net loss of Rs 20.83 crore, while it had reported a net loss of Rs 50.89 lakh during the previous year, AstraZeneca Pharma said in a filing to the BSE.